A biotechnology company serving gene therapy developers is opening a manufacturing facility for engineered viruses that deliver gene therapies. . . . → Read More: Biotech Opens Gene Therapy Manufacturing Facility
|
|||||
|
       
  |
A company designing synthetic DNA and RNA says reference materials are available for tests that detect the quickly spreading Covid-19 delta variant. . . . → Read More: Covid-19 Delta Variant Testing Reference Released 
A start-up company creating synthetic blood vessels for transplants, based on research in materials science and cell biology, is raising $2.2 million in seed funds. . . . → Read More: Synthetic Blood Vessel Maker Gains $2.2M in Seed Funds  Comments are closed  Finance, New products  biomedical, biotechnology, chemistry, engineering, entrepreneurs, equity, Europe, investment, life sciences, materials science, medical device, physical sciences, university, venture capital 
A developer of treatments for people with amyotrophic lateral sclerosis, or ALS, is raising $135 million in its third venture financing round. . . . → Read More: ALS Drug Maker Gains $135M in New Funds Comments are closed Finance, New products biomedical, biotechnology, clinical trials, entrepreneurs, equity, investment, life sciences, pharmaceuticals, venture capital 
Combining commercial saliva tests to speed detection of the SARS-CoV-2 virus in schools is shown as accurate as individual gold-standard nasal swab tests. . . . → Read More: Pooled Saliva Tests Detect Covid-19 in Schools One comment - (Comments are closed) New products biomedical, clinical trials, Covid-19, genomics, health care, life sciences, medical device, university 
Eli Lilly and Company is partnering with an Alzheimer’s disease research center to test a synthetic antibody for preventing the disorder in at-risk individuals. . . . → Read More: Trial to Test Antibody Drug for Alzheimer’s Prevention Comments are closed Joint ventures/collaborations, New products biomedical, biotechnology, clinical trials, genomics, life sciences, medical device, pharmaceuticals 
A biotechnology company developing cancer therapies with natural killer cells in the immune system is raising $172 million in its second venture round. . . . → Read More: Immune Cell Cancer Biotech Gains $172M in New Funds Comments are closed Finance, New products biomedical, biotechnology, cancer, clinical trials, entrepreneurs, equity, investment, pharmaceuticals, university, venture capital 
A new challenge competition aims to build a distributed network of facilities to design, develop, and manufacture RNA-based biologic products. . . . → Read More: $60M Challenge Seeks RNA Bio-Production Network One comment - (Comments are closed) Finance, New products biomedical, biotechnology, challenge, Covid-19, engineering, genomics, life sciences, manufacturing, pharmaceuticals, semiconductors, software 
A biotechnology company says it discovers therapies with the gene-editing technique Crispr to carry out a wider range of precise genomic corrections. . . . → Read More: Precision Gene-Editing Biotech Gains $200M in New Funds Comments are closed Finance, New products biomedical, biotechnology, entrepreneurs, equity, genomics, investment, life sciences, pharmaceuticals, university 
A clinical trial enrolled its first participant testing the safety of a treatment for lymphoma, a type of cancer, using the gene-editing technique Crispr. . . . → Read More: Trial Underway for Crispr Lymphoma Therapy One comment - (Comments are closed) New products biomedical, biotechnology, cancer, clinical trials, genomics, life sciences, university |
||||
|
Copyright © 2021 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||